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• Objectives:
– To assess the situation in Europe 
regarding the problem of alcohol 
and/or other psychoactive 
substances relation to road safety 
• Prevalence in the general 
population
• Prevalence in the driving 
population
• Risk of injury for drink and/or 
drug drivers
• Characteristics of drink and 
drug drivers 
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DRUID PROJECT - Epidemiology
• Reviews
• An overview of the prevalence in 
general consumption in Europe
• Prevalence studies of drugs
• In the driving population
• In injured/killed drivers
• In drivers in fatal accidents
• Risk while drink and drug driving
• Risk of being injured or killed
• Risk of being crash responsible
• Accident risk for medicine users
• Interviews
• Motives to impaired driving
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Psychoactive substances in question
• Alcohol
• Illicit drugs
– Amphetamines, including methamphetamines and MDA, MDEA and MDMA
– Cocaine and benzoylecgonine
– Cannabis
– Illicit opiates
• Medicines
– Benzodiazepines
– Z-drugs
– Medicinal opioids
• Alcohol in combination with other drugs
• Multiple drugs
• Positive concentrations are based on
the same uniform cut-offs in all studies
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Review  
• Prevalence of psychoactive substances in
the general population (D 2.1.1)
Method:
Literature study
Main results:
An increase in psychotropic medicines 
and medicines with central nervous 
system side-effects was observed, a.o.
benzodiazepines
Z-drugs
opioids
The major increase in the consumption of 
antidepressants and drugs used in 
addictive disorders was observed 
For the other classes of interest either a 
slight increase or no increase was noted
24.09.2011
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Prevalence studies
• Alcohol and other psychoactive substances 
in drivers in the general traffic (D 2.2.3)
Aim of the roadside surveys:
To estimate the prevalence of 
psychoactive substances, including 
alcohol in the general driving 
population 
To identify similarities and 
differences in the involved countries
To estimate the size of the problem
on a European basis 
Method: 
Roadside surveys in 13 countries by 
means of a uniform protocol in all 
countries
In total data from more than 50.000 drivers was collected at the roadside
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Prevalence studies
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Alcohol is still the most prevalent substance in the driving population
- but most of the drink driving is with concentrations below 0.5 g/L
Prevalence of alcohol
Alcohol in the general traffic
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Prevalence of alcohol in 
combination with other drugs
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Prevalence studies
Illicit drugs are most prevalent in southern and western Europe
Driving with medicines is observed all over Europe
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Prevalence of illicit drugs
Prevalence of medicines
Illicit and medicinal drugs in the general traffic
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Prevalence studies
• Psychoactive substances and consumption 
patterns in traffic (D 2.2.2)
Aim of the smart phone study:
To investigate the frequency of drug 
driving incidences among drug users 
compared with non-users
To investigate situational aspects of drug 
driving Incidences 
Method:
Data collection of information on driving 
patterns by means of smartphones
24.09.2011
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Prevalence studies 
• Drug users compared to non-users
– More mobile at night 
– But less nighttime drives 
– Consumption of alcohol more frequently and in higher doses
– Double prevalence of drink driving
Prevalence when driving 
for drug users
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Prevalence studies
• Alcohol and other drugs in injured and killed 
drivers (D 2.2.5)
Aim of the studies on accident involved drivers:
To estimate the prevalence of psychoactive 
substances including alcohol in seriously 
injured drivers and in killed drivers
To identify similarities and differences in the 
involved countries 
To estimate the size of the problem on a 
European basis
Method: 
Study of seriously injured drivers in 6 
countries and study of killed drivers in 4 
countries, by means of a uniform protocol 
for all countries
The results are based on data from app. 2600 seriously injured and 1000 killed drivers 
24.09.2011
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Prevalence studies
Alcohol in injured and killed drivers
Seriously injured drivers
0
10
20
30
40
DK FI LT IT BE NL
%
Alone
In combination
Killed drivers
0
10
20
30
40
FI NO SE PT
%
Alcohol only
In combination
Among the alcohol positive drivers – both seriously injured and killed, the majority had 
a blood alcohol concentration equal to or above 0,5 g/L
Combined use of alcohol combined with other drugs is considerable in a number of 
countries
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Prevalence studies
Illicit and medicinal drugs in injured and killed
drivers  
For most illicit drugs and medicines, the percentage of combined drug use exceeded 
that of single drug use
Seriously injured drivers
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Prevalence studies
• Alcohol and illicit drugs in drivers in fatal 
accidents (D 2.2.4)
Aim of the prevalence study:
To estimate the prevalence 
in all types of drivers in 
fatal accidents
Method: 
Systematic testing of all 
drivers in a fatal accident i 
France
- Killed, injured and non 
injured
- Alcohol and illicit drugs
- Data from 10,519 drivers
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Relative risk studies
• Risk of injury by driving with alcohol and 
other drugs (D 2.3.5)
Aim of the risk study:
To assess the risk for
- alcohol
- illicit drugs and medicines
- alcohol combined with drugs
- multiple drug use
To demonstrate the relation between drug 
impairment and traffic accidents 
To serve as input to the discussion on 
impairment thresholds 
Method: 
Case-control study based on data from 
seriously injured /killed drivers (cases)
and data from road side surveys (controls)
Seriously injured drivers: DK, FI, LT, IT, BE, NL, H, killed drivers: FI, NO, SE, PT
24.09.2011
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Relative risk studies
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Relative risk studies
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Relative risk studies
• Risk of accident responsibility by driving with 
alcohol and other drugs (D 2.3.2, D 2.3.3, D 2.3.4)
Aim of the risk studies :
To assess the relative risk for 
killed drivers who were 
responsible for their accidents
or
To assess the relative risk for 
responsible drivers involved in 
a fatal road accident
Method: 
Three case-control studies
- killed drivers (2 studies)
- drivers in fatal accidents (1 study)
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Relative risk studies
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Relative risk studies
• Relative risk of patients using psychotropic medicines  
( D 2.3.1)
Aim:
To assess
- accident risk of drivers using 
psychoactive medicines compared 
to non-users
-risk when using a combination of 
(psychoactive) medicines
Method: 
A pharmacoepidemiological study, 
linking databases in the Netherlands
- pharmacy prescription
- police registered traffic accidents 
- driving licenses
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Driver characteristics
• Motives behind risky driving  - driving under 
the influence of alcohol and drugs (D 2.2.1)
Aim of the study:
To explore the motives to
drink and drug driving
Method:
Qualitative interviews
Drivers do not think that their driving is influenced
- alcohol does not impair drivng
- but drug improves driving
Drink drivers feel more ashamed than drug drivers
Loosing the license or imprisonment would  not have helped
- rehabilitation is recommend
24.09.2011
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DRUID PROJECT - Epidemiology
For more information, see www.druid-project.eu
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